This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Brookdale (BKD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
Brookdale (BKD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Down -20.05% in 4 Weeks, Here's Why Brookdale (BKD) Looks Ripe for a Turnaround
by Zacks Equity Research
Brookdale (BKD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Brookdale Senior Living (BKD) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
Why Fast-paced Mover Brookdale (BKD) Is a Great Choice for Value Investors
by Zacks Equity Research
Brookdale (BKD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Ensign Group (ENSG) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 2.73% and 4.77%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Fast-paced Momentum Stock Brookdale (BKD) Is Still Trading at a Bargain
by Zacks Equity Research
Brookdale (BKD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Brookdale (BKD) Q1 Adjusted EBITDA to Beat View, Occupancy Up
by Zacks Equity Research
Brookdale Senior Living (BKD) witnesses 17 straight months of year-over-year increases in weighted average occupancy level.
Brookdale Senior (BKD) February Weighted Average Occupancy Up
by Zacks Equity Research
Brookdale Senior Living (BKD) witnesses 16 straight months of year-over-year increases in weighted average occupancy level.
Brookdale Senior Living (BKD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of 69.77% and 1.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Brookdale Senior Living (BKD) Report Negative Q4 Earnings? What You Should Know
by Zacks Equity Research
Brookdale (BKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Group (ENSG) Matches Q4 Earnings Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 0% and 1.22%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Down -8.3% in 4 Weeks, Here's Why Brookdale (BKD) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Brookdale (BKD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Brookdale Senior Living (BKD) Q4 Weighted Average Occupancy Up
by Zacks Equity Research
Brookdale Senior Living (BKD) witnesses 14 straight months of year-over-year increases in weighted average occupancy level.
Brookdale Senior Living (BKD) Reports Q3 Loss
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -15.38% and 0%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Brookdale Senior Living (BKD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Brookdale (BKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Group (ENSG) Q3 Earnings Lag Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of -0.95% and 2.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Acadia (ACHC) JV Breaks Ground for New Behavioral Health Unit
by Zacks Equity Research
Acadia Healthcare (ACHC) and Henry Ford Health expect the new hospital to start with 184 inpatient beds and later expand to 192 beds.
Brookdale (BKD) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Brookdale (BKD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Has Brookdale Senior Living (BKD) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Brookdale Senior Living (BKD) and Hanger (HNGR) have performed compared to their sector so far this year.
All You Need to Know About Brookdale (BKD) Rating Upgrade to Buy
by Zacks Equity Research
Brookdale (BKD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Brookdale Senior Living (BKD) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -9.76% and 0.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Meets Q2 Earnings Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 0% and 0.60%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Brookdale Senior Living (BKD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Brookdale (BKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brookdale Senior Living (BKD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -45.95% and 1.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 3.13% and 1.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?